Cirius Therapeutics, Inc. — Form D

Cirius Therapeutics, Inc. of GRAND RAPIDS, MI, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-10. The offering totals $40.5M, of which $30.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Robert BalteraDirectorKalamazoo, MI
Daniel EstesDirectorCarmel, IN
Nilesh KumarDirectorWatertown, MA
Robert BalteraExecutive OfficerKalamazoo, MI
Howard DittrichExecutive OfficerKalamazoo, MI
Michael A JandernoaDirectorGrand Rapids, MI
Robert A BeardsleyExecutive OfficerGrand Rapids, MI
Robert A ZerbeDirectorGrand Rapids, MI
David A Van AndelDirectorGrand Rapids, MI
Jerry A CallahanExecutive OfficerGrand Rapids, MI
David Van AndelDirectorGrand Rapids, MI
Michael JandernoaDirectorKalamazoo, MI
Mark OlesnavageExecutive OfficerKalamazoo, MI
Robert BeardsleyExecutive OfficerSt. Louis, MO
Jerry CallahanExecutive OfficerGrand Rapids, MI
Robert ZerbeDirectorGrand Rapids, MI
Elaine SunDirectorSOUTH SAN FRANCISCO, CA
Daniel Estes, Ph.D.DirectorMenlo Park, CA
Baltera BobDirectorSan Diego, CA
Baltera BobExecutive OfficerSan Diego, CA
Nilesh Kumar, Ph.D.DirectorSan Diego, CA
Robert Zerbe, M.D.DirectorSan Diego, CA
Dennis Fenton, Ph.D.DirectorSan Diego, CA
Brian FarmerExecutive OfficerSan Diego, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2025-10-08D$1.2M$800K
2024-10-15D$1.6M$1.0M
2024-08-20D$1.3M$1.3M
2019-05-14D$7.5M$7.5M
2018-08-30D$9.0M$9.0M

More